
Accelerate Diagnostics AXDX
Quarterly report 2024-Q3
added 11-07-2024
Accelerate Diagnostics Depreciation & Amortization 2011-2026 | AXDX
Annual Depreciation & Amortization Accelerate Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.7 M | 2 M | 2.4 M | 2.3 M | 2.5 M | 2.2 M | 2.3 M | 1.8 M | 817 K | 286 K | 2 K | 2.4 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.5 M | 2 K | 1.53 M |
Quarterly Depreciation & Amortization Accelerate Diagnostics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 343 K | 351 K | - | 315 K | 354 K | 355 K | - | 381 K | 443 K | 460 K | - | 487 K | 493 K | 600 K | - | 581 K | 637 K | 600 K | - | 600 K | 500 K | 600 K | - | 700 K | 500 K | 500 K | - | 550 K | 540 K | 505 K | - | 598 K | 605 K | 542 K | - | 465 K | 403 K | 326 K | - | 251 K | 150 K | 134 K | - | 84 K | 71 K | 36 K | 515 | 551 | 515 | 1.81 K | 599 | 515 | 1.2 K | 515 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 700 K | 515 | 350 K |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 18.56 | 10.74 % | $ 196 M | ||
|
Agilent Technologies
A
|
321 M | - | - | $ 34.4 B | ||
|
Castle Biosciences
CSTL
|
40.8 M | $ 18.88 | 4.02 % | $ 547 M | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 16.19 | 1.44 % | $ 490 M | ||
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
15 M | $ 20.49 | -0.58 % | $ 1.09 B | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 419.17 | -1.08 % | $ 12.1 B | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
70.1 M | - | - | $ 6.5 B | ||
|
Mettler-Toledo International
MTD
|
51.1 M | $ 1 041.91 | 1.75 % | $ 21.5 B | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 3.62 | -2.95 % | $ 335 M | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
1.11 M | $ 1.63 | 1.87 % | $ 2.17 M | ||
|
NeoGenomics
NEO
|
36.1 M | $ 8.36 | 1.21 % | $ 1.07 B | ||
|
National Research Corporation
NRC
|
7.62 M | $ 18.93 | 1.39 % | $ 424 M | ||
|
Natera
NTRA
|
16.7 M | $ 196.91 | 0.81 % | $ 19.4 B | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 159.12 | -2.29 % | $ 7.89 B | ||
|
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 25.5 | -0.51 % | $ 24.2 B | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Personalis
PSNL
|
10 M | $ 6.71 | 5.01 % | $ 599 M | ||
|
Guardant Health
GH
|
39.7 M | $ 98.66 | 0.19 % | $ 12.4 B | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 5.82 | 5.82 % | $ 243 M | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 117.09 | -0.25 % | $ 9.66 B | ||
|
Illumina
ILMN
|
354 M | $ 143.24 | -1.21 % | $ 22.8 B | ||
|
Soleno Therapeutics
SLNO
|
2.02 M | $ 52.99 | 0.08 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
24.9 M | $ 52.95 | -2.65 % | $ 3.17 B | ||
|
Biomerica
BMRA
|
87 K | $ 2.41 | 7.11 % | $ 5.54 M | ||
|
Thermo Fisher Scientific
TMO
|
1.05 B | $ 448.21 | 0.49 % | $ 169 B | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 254.02 | -0.16 % | $ 21.1 B | ||
|
Waters Corporation
WAT
|
88.1 M | $ 333.21 | -0.51 % | $ 19.8 B | ||
|
Celcuity
CELC
|
167 K | $ 134.72 | 8.23 % | $ 6.3 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
119 M | $ 8.43 | -2.99 % | $ 1.83 B |